Investigational Drug Information for PF-06700841
✉ Email this page to a colleague
What is the drug development status for PF-06700841?
PF-06700841 is an investigational drug.
There have been 21 clinical trials for PF-06700841.
The most recent clinical trial was a Phase 2 trial, which was initiated on December 15th 2016.
The most common disease conditions in clinical trials are Psoriasis, Alopecia Areata, and Alopecia. The leading clinical trial sponsors are Pfizer, Emma Guttman, and [disabled in preview].
There are two US patents protecting this investigational drug and fifty-two international patents.
Summary for PF-06700841
| US Patents | 2 |
| International Patents | 52 |
| US Patent Applications | 16 |
| WIPO Patent Applications | 7 |
| Japanese Patent Applications | 1 |
| Clinical Trial Progress | Phase 2 (2016-12-15) |
| Vendors | 14 |
Recent Clinical Trials for PF-06700841
| Title | Sponsor | Phase |
|---|---|---|
| Dual JAK1/TYK2 Inhibitor for Cicatricial Alopecia | Pfizer | Phase 2 |
| Dual JAK1/TYK2 Inhibitor for Cicatricial Alopecia | Emma Guttman | Phase 2 |
| Clinical Study to Evaluate Pharmacokinetics and Safety of PF-06700841 After Single and Multiple Oral Doses as Modified Release Formulations | Pfizer | Phase 1 |
Clinical Trial Summary for PF-06700841
Top disease conditions for PF-06700841
Top clinical trial sponsors for PF-06700841
US Patents for PF-06700841
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| PF-06700841 | ⤷ Sign Up | Aminopyrimidinyl compounds | Pfizer Inc. (New York, NY) | ⤷ Sign Up |
| PF-06700841 | ⤷ Sign Up | Aminopyrimidinyl compounds | Pfizer Inc. (New York, NY) | ⤷ Sign Up |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for PF-06700841
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| PF-06700841 | Argentina | AR101599 | 2034-08-21 | ⤷ Sign Up |
| PF-06700841 | Australia | AU2015304883 | 2034-08-21 | ⤷ Sign Up |
| PF-06700841 | Brazil | BR112017003054 | 2034-08-21 | ⤷ Sign Up |
| PF-06700841 | Canada | CA2900855 | 2034-08-21 | ⤷ Sign Up |
| PF-06700841 | Chile | CL2017000406 | 2034-08-21 | ⤷ Sign Up |
| PF-06700841 | China | CN107074867 | 2034-08-21 | ⤷ Sign Up |
| PF-06700841 | Colombia | CO2017001603 | 2034-08-21 | ⤷ Sign Up |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
